J&J COVID-19 vaccine in limbo as U.S. panel delays vote on resuming shots
(Reuters) -Johnson & Johnson’s COVID-19 vaccine remained in limbo on Wednesday as a U.S. health panel called for more data …
Home »
(Reuters) -Johnson & Johnson’s COVID-19 vaccine remained in limbo on Wednesday as a U.S. health panel called for more data …
WASHINGTON (Reuters) -The U.S. Centers for Disease Control and Prevention on Friday said fully vaccinated people can safely travel at …